Top Monoclonal serpine1 antibody
Inhibition of SERPINE1/protease nexin-1 by a monoclonal antibody attenuates airway reworking in a murine mannequin of bronchial asthma.
- SERPINE1, often known as protease nexin-1 (PN-1), is a serine protease inhibitor produced by many cell sorts and has pleiotropic organic capabilities. It has been reported that SERPINE1/PN-1 is concerned in tissue reworking of fibrotic ailments together with idiopathic pulmonary fibrosis and cardiac fibrosis.
Monoclonal SERPINE1 Antibody (monoclonal) (M01), Clone: 3F2
- Nevertheless, the potential position of SERPINE1/PN-1 in asthmatic airway reworking has remained barely investigated up to now. On this examine, BALB/c male mice have been sensitized and challenged by ovalbumin to generate murine fashions of airway reworking.
- Anti-SERPINE1monoclonal antibody was intraperitoneally injected into these mice through the ovalbumin problem whereas IgG antibody was used as a car management.
Mouse Monoclonal Antibody to Human Topoisomerase IIIα
- The outcomes revealed that the expression of SERPINE1/PN-1 was considerably upregulated within the lung extracts of ovalbumin-challenged mice, and this upregulation was inhibited by dexamethasone. Sustained ovalbumin stimulation elevated the thickness of airway wall and α-SMA optimistic areas in lung, which was attenuated by the remedy with SERPINE1antibody.
- As well as, SERPINE1antibody partially blocked the phosphorylation of ERK, and lowered the upregulation of MMP-9 and TIMP-1 expressions in asthmatic mice. These findings recommend that SERPINE1/PN-1 could play a job within the pathologic improvement of airway reworking. Monoclonal antibody towards SERPINE1could have the potential as an efficient pharmacotherapy for asthmatic airway reworking.
 Monoclonal SERPINE1 / PAI-1 Antibody |
|||
| AMR09879G | Leading Biology | 0.05ml | EUR 484 |
 Monoclonal SERPINE1 Antibody, Clone: 1D5 |
|||
| APR13266G | Leading Biology | 0.1ml | EUR 528 |
 (M01), Clone: 3F2) Monoclonal SERPINE1 Antibody (monoclonal) (M01), Clone: 3F2 |
|||
| AMR09883G | Leading Biology | 0.1mg | EUR 484 |
 SERPINE1 antibody |
|||
| 70R-20178 | Fitzgerald | 50 ul | EUR 435 |
 SERPINE1 Antibody |
|||
| 35861-100ul | SAB | 100ul | EUR 252 |
SERPINE1 antibody |
|||
| 38751-100ul | SAB | 100ul | EUR 252 |
SERPINE1 Antibody |
|||
| 1-CSB-PA003699 | Cusabio |
|
|
|
|||
SERPINE1 Antibody |
|||
| 1-CSB-PA11239A0Rb | Cusabio |
|
|
|
|||
SERPINE1 Antibody |
|||
| 1-CSB-PA122189 | Cusabio |
|
|
|
|||
SERPINE1 antibody |
|||
| 70R-9710 | Fitzgerald | 50 ug | EUR 467 |
SERPINE1 antibody |
|||
| 70R-9711 | Fitzgerald | 50 ug | EUR 467 |
SERPINE1 antibody |
|||
| 70R-5413 | Fitzgerald | 50 ug | EUR 467 |
SERPINE1 antibody |
|||
| 70R-5427 | Fitzgerald | 50 ug | EUR 467 |
SERPINE1 Antibody |
|||
| BF0086 | Affbiotech | 200ul | EUR 376 |
SERPINE1 Antibody |
|||
| 1-CSB-PA021081GA01HU | Cusabio |
|
|
|
|||
 Mouse Monoclonal Antibody to Human Topoisomerase IIα |
|||
| TG2010-1 | TopoGen | 50 units | EUR 369 |
 Mouse Monoclonal Antibody to Human Topo IIB |
|||
| TG2011-5 | TopoGen | 100 units | EUR 380 |
 Mouse Monoclonal Antibody to Human Topoisomerase I |
|||
| TG2012-4 | TopoGen | 100 ug | EUR 380 |
 Mouse Monoclonal Antibody to Human Topoisomerase IIIα |
|||
| TG2015 | TopoGen | 50 ul | EUR 436 |
 SERPINE1 Conjugated Antibody |
|||
| C35861 | SAB | 100ul | EUR 397 |
) SERPINE1 Antibody (Biotin) |
|||
| abx430278-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
 SERPINE1 Polyclonal Antibody |
|||
| A52260 | EpiGentek | 100 µg | EUR 570.55 |
 Anti-SERPINE1 antibody |
|||
| STJ25488 | St John's Laboratory | 100 µl | EUR 277 |
Anti-SERPINE1 antibody |
|||
| STJ27967 | St John's Laboratory | 100 µl | EUR 277 |
Anti-SERPINE1 antibody |
|||
| STJ113996 | St John's Laboratory | 100 µl | EUR 277 |
Anti-SERPINE1 antibody |
|||
| STJ116958 | St John's Laboratory | 100 µl | EUR 277 |
, Clone: 1D5) Monoclonal SERPINE1 / PAI-1 Antibody (clone 1D5), Clone: 1D5 |
|||
| AMR09880G | Leading Biology | 0.05mg | EUR 484 |
 SERPINE1 Protein |
|||
| abx069901-05mg | Abbexa | 0.5 mg | EUR 1970 |
|
|||
 SERPINE1 siRNA |
|||
| 20-abx933011 | Abbexa |
|
|
|
|||
SERPINE1 siRNA |
|||
| 20-abx933012 | Abbexa |
|
|
|
|||
 SERPINE1 Antibody, HRP conjugated |
|||
| 1-CSB-PA11239B0Rb | Cusabio |
|
|
|
|||
 SERPINE1 Antibody, FITC conjugated |
|||
| 1-CSB-PA11239C0Rb | Cusabio |
|
|
|
|||
 SERPINE1 Antibody, Biotin conjugated |
|||
| 1-CSB-PA11239D0Rb | Cusabio |
|
|
|
|||
 Anti-PAI1/Serpine1 Antibody |
|||
| A00637-2 | BosterBio | 100ug/vial | EUR 294 |
 Anti-PAI1 / SERPINE1 antibody |
|||
| STJ70687 | St John's Laboratory | 100 µg | EUR 359 |
 (pORF)) Serpine1 ORF Vector (Mouse) (pORF) |
|||
| ORF057058 | ABM | 1.0 ug DNA | EUR 506 |
 (OKCD06429)) SERPINE1 ELISA Kit (Mouse) (OKCD06429) |
|||
| OKCD06429 | Aviva Systems Biology | 96 Wells | EUR 779 |
 SERPINE1 Rabbit pAb |
|||
| A12102-100ul | Abclonal | 100 ul | EUR 308 |
SERPINE1 Rabbit pAb |
|||
| A12102-200ul | Abclonal | 200 ul | EUR 459 |
SERPINE1 Rabbit pAb |
|||
| A12102-20ul | Abclonal | 20 ul | EUR 183 |
SERPINE1 Rabbit pAb |
|||
| A12102-50ul | Abclonal | 50 ul | EUR 223 |
SERPINE1 Rabbit pAb |
|||
| A1297-100ul | Abclonal | 100 ul | EUR 308 |
SERPINE1 Rabbit pAb |
|||
| A1297-200ul | Abclonal | 200 ul | EUR 459 |
SERPINE1 Rabbit pAb |
|||
| A1297-20ul | Abclonal | 20 ul | Ask for price |
SERPINE1 Rabbit pAb |
|||
| A1297-50ul | Abclonal | 50 ul | Ask for price |
SERPINE1 Rabbit pAb |
|||
| A14758-100ul | Abclonal | 100 ul | EUR 308 |
SERPINE1 Rabbit pAb |
|||
| A14758-200ul | Abclonal | 200 ul | EUR 459 |
SERPINE1 Rabbit pAb |
|||
| A14758-20ul | Abclonal | 20 ul | EUR 183 |
SERPINE1 Rabbit pAb |
|||
| A14758-50ul | Abclonal | 50 ul | EUR 223 |
 SERPINE1 Blocking Peptide |
|||
| 33R-9417 | Fitzgerald | 100 ug | EUR 180 |
SERPINE1 Blocking Peptide |
|||
| 33R-9703 | Fitzgerald | 100 ug | EUR 180 |
SERPINE1 Blocking Peptide |
|||
| BF0086-BP | Affbiotech | 1mg | EUR 195 |
 SERPINE1 cloning plasmid |
|||
| CSB-CL021081HU-10ug | Cusabio | 10ug | EUR 233 |
|
|||
SERPINE1 Rabbit pAb |
|||
| A6211-100ul | Abclonal | 100 ul | EUR 308 |
SERPINE1 Rabbit pAb |
|||
| A6211-200ul | Abclonal | 200 ul | EUR 459 |
SERPINE1 Rabbit pAb |
|||
| A6211-20ul | Abclonal | 20 ul | EUR 183 |
SERPINE1 Rabbit pAb |
|||
| A6211-50ul | Abclonal | 50 ul | EUR 223 |
) anti-SERPINE1 (1D5) |
|||
| LF-MA30668 | Abfrontier | 100 ul | EUR 527 |
 pCMV-SPORT6-SERPINE1 |
|||
| PVT13105 | Lifescience Market | 2 ug | EUR 391 |
) Polyclonal SERPINE1 Antibody (C-term) |
|||
| AMR09882G | Leading Biology | 0.1ml | EUR 484 |
 SERPINE1 Polyclonal Antibody, Biotin Conjugated |
|||
| A52258 | EpiGentek | 100 µg | EUR 570.55 |
 SERPINE1 Polyclonal Antibody, FITC Conjugated |
|||
| A52259 | EpiGentek | 100 µg | EUR 570.55 |
 SERPINE1 Polyclonal Antibody, HRP Conjugated |
|||
| A52261 | EpiGentek | 100 µg | EUR 570.55 |
 Anti-PAI1 / SERPINE1, Biotinylated antibody |
|||
| STJ73264 | St John's Laboratory | 100 µg | EUR 359 |
) Mouse Plasminogen activator inhibitor 1 (Serpine1) |
|||
| 1-CSB-EP021081MO | Cusabio |
|
|
|
|||
Mouse Plasminogen activator inhibitor 1 (Serpine1) |
|||
| 1-CSB-YP021081MO | Cusabio |
|
|
|
|||
) Serpine1 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3989401 | ABM | 3 x 1.0 ug | EUR 339 |
) Mouse IgG1 Monoclonal Clone: S5 to Hsp70 (Clone S5) |
|||
| 3096-100 | Biovision | 100 ug | EUR 371 |
|
|||
) Polyclonal SERPINE1 / PAI-1 Antibody (Internal) |
|||
| AMR09881G | Leading Biology | 0.05mg | EUR 484 |
 Antibody) Plasminogen Activator Inhibitor 1 (SERPINE1) Antibody |
|||
| 20-abx110098 | Abbexa |
|
|
|
|||
 Serpine1 mRNA Binding Protein 1 Antibody |
|||
| 20-abx115480 | Abbexa |
|
|
|
|||
Plasminogen Activator Inhibitor 1 (SERPINE1) Antibody |
|||
| 20-abx132062 | Abbexa |
|
|
|
|||
Plasminogen Activator Inhibitor 1 (SERPINE1) Antibody |
|||
| 20-abx132063 | Abbexa |
|
|
|
|||
Plasminogen Activator Inhibitor 1 (SERPINE1) Antibody |
|||
| 20-abx132064 | Abbexa |
|
|
|
|||
 Polyclonal Goat Anti-PAI1 / SERPINE1 Antibody |
|||
| AMM05071G | Leading Biology | 0.1 mg | EUR 484 |
 Human SERPINE1 ELISA Kit |
|||
| ELA-E0532h | Lifescience Market | 96 Tests | EUR 824 |
 SERPINE1 ELISA KIT|Human |
|||
| EF001945 | Lifescience Market | 96 Tests | EUR 689 |
 Rat SERPINE1 shRNA Plasmid |
|||
| 20-abx984567 | Abbexa |
|
|
|
|||
 Human SERPINE1 shRNA Plasmid |
|||
| 20-abx953360 | Abbexa |
|
|
|
|||
 Rat SERPINE1 ELISA Kit |
|||
| STJ150389 | St John's Laboratory | 1 kit | EUR 412 |
) Mouse IgG1 Monoclonal Clone: C33 to Caspase-3 (Clone C33) |
|||
| 3004-100 | Biovision | 100 ug | EUR 388 |
|
|||
 (Target 1)) Serpine1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3989402 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) Serpine1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3989403 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) Serpine1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3989404 | ABM | 1.0 ug DNA | EUR 154 |
 (pPB-C-His)) SERPINE1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV228230 | ABM | 500 ng | EUR 603 |
 (pPB-N-His)) SERPINE1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV228231 | ABM | 500 ng | EUR 603 |
 (pPM-C-HA)) SERPINE1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV228232 | ABM | 500 ng | EUR 603 |
 (pPM-C-His)) SERPINE1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV228233 | ABM | 500 ng | EUR 603 |
Two years’ expertise with denosumab for youngsters with osteogenesis imperfecta sort VI.
BACKGROUND
Osteogenesis imperfecta (OI) is a hereditary illness inflicting lowered bone mass, elevated fracture charge, lengthy bone deformities and vertebral compressions.
Plasminogen Activator Inhibitor 1 (SERPINE1) Antibody
Extra non skeletal findings are attributable to impaired collagen perform and embrace hyperlaxity of joints and blue sclera. Most OI circumstances are attributable to dominant mutations in COL1A1/2 affecting bone formation. Over the last years, recessive types of OI have been recognized, largely affecting posttranslational modification of collagen.
In 2011, mutations in SERPINF1 have been recognized because the molecular explanation for OI sort VI, and thereby a novel pathophysiology of the illness was elucidated. The subgroup of sufferers with OI sort VI are affected by an elevated bone resorption, resulting in the identical signs as noticed in sufferers with an impaired bone formation. Severely affected youngsters are presently handled with intravenous bisphosphonates whatever the underlying mutation and pathophysiology. Sufferers with OI sort VI are identified to have a poor response to such a bisphosphonate remedy.
METHODS
Deciphering the genetic explanation for OI sort VI in our four sufferers (three youngsters and one adolescent) led to a direct translational strategy within the type of a remedy with the monoclonal RANKL antibody Denosumab (1 mg/kg physique weight each 12 weeks).
0,1ML THIN WALL TUBES eight PER STRIP. WHITE & REAL TIME STRIP CAPS
RESULTS
Quick-term biochemical response to this remedy was reported beforehand. We now current the outcomes after 2 years of remedy and reveal a long run profit in addition to a rise of bone mineral density, a normalization of vertebral form, a rise of mobility, and a lowered fracture charge.
 500-10000bp DNA Marker, Ready-to-use |
|||
| M101R-2 | Bio Basic | 5x100loading, 500prep | EUR 219.65 |
|
|||
 100-1500bp DNA Marker, Ready-to-use |
|||
| M102R-2 | Bio Basic | 5x100loading, 500prep | EUR 215.3 |
|
|||
 Lambda DNA/HindIII Marker, Ready-to-use |
|||
| M104R-2 | Bio Basic | 5x100loading, 500prep | EUR 124.82 |
|
|||
 Lambda DNA/HindIII Plus, Ready-to-use |
|||
| M105R-2 | Bio Basic | 5x100loading, 500prep | EUR 115.25 |
|
|||
100-1500bp DNA Marker, Ready-to-use |
|||
| M107R-2 | Bio Basic | 5x100loading, 500prep | EUR 219.65 |
|
|||
) p53; Clone BP53-12 (Ready-To-Use) |
|||
| A00109-0002 | ScyTek Laboratories | 2 ml | EUR 111 |
p53; Clone BP53-12 (Ready-To-Use) |
|||
| A00109-0007 | ScyTek Laboratories | 7 ml | EUR 183 |
p53; Clone BP53-12 (Ready-To-Use) |
|||
| A00109-0025 | ScyTek Laboratories | 25 ml | EUR 449 |
 0.2ML THIN WALL CLEAR PCR FLAT STRIP CAPS. 12 CAPS PER STRIP |
|||
| PCR-12-FCP-C | CORNING | 80/pk | EUR 154 |
) Cytokeratin 8; Clone K8/383 (Ready-To-Use) |
|||
| A00136-0002 | ScyTek Laboratories | 2 ml | EUR 92 |
Cytokeratin 8; Clone K8/383 (Ready-To-Use) |
|||
| A00136-0007 | ScyTek Laboratories | 7 ml | EUR 156 |
Cytokeratin 8; Clone K8/383 (Ready-To-Use) |
|||
| A00136-0025 | ScyTek Laboratories | 25 ml | EUR 367 |
) CA15-3 (Ready-To-Use) |
|||
| A00078-0002 | ScyTek Laboratories | 2 ml | EUR 84 |
CA15-3 (Ready-To-Use) |
|||
| A00078-0007 | ScyTek Laboratories | 7 ml | EUR 116 |
CA15-3 (Ready-To-Use) |
|||
| A00078-0025 | ScyTek Laboratories | 25 ml | EUR 245 |
) Melanoma; Pan (Ready-To-Use) |
|||
| A00134-0002 | ScyTek Laboratories | 2 ml | EUR 140 |
Melanoma; Pan (Ready-To-Use) |
|||
| A00134-0007 | ScyTek Laboratories | 7 ml | EUR 272 |
Melanoma; Pan (Ready-To-Use) |
|||
| A00134-0025 | ScyTek Laboratories | 25 ml | EUR 717 |
) Mirskys Fixative (ready-to-use) |
|||
| NAT1300 | National Diagnostics | 1USGALLON | EUR 80 |
Mirskys Fixative (ready-to-use) |
|||
| NAT1302 | National Diagnostics | EACH | EUR 190 |
 Eco-Stain, ready to use |
|||
| DT81413 | Bio Basic | 1ml | EUR 102.2 |
|
|||
 0.2ML CLEAR STRIP CAPS FOR REAL TIME PCR |
|||
| PCR-2CP-RT-C | CORNING | 125/pk | EUR 223 |
) Bcl-2; Clone 124 (Ready-To-Use) |
|||
| A00004-0002 | ScyTek Laboratories | 2 ml | EUR 124 |
Bcl-2; Clone 124 (Ready-To-Use) |
|||
| A00004-0007 | ScyTek Laboratories | 7 ml | EUR 197 |
Bcl-2; Clone 124 (Ready-To-Use) |
|||
| A00004-0025 | ScyTek Laboratories | 25 ml | EUR 569 |
 0.2ML THIN WALL CLEAR PCR STRIP TUBES, 12 TUBES PER STRIP |
|||
| PCR-0212-C | CORNING | 80/pk | EUR 611 |
 0,1ML THIN WALL TUBES 8 PER STRIP. CLEAR & REAL TIME STRIP CAPS |
|||
| PCR-0108-LP-RT-C | CORNING | 125/pk | EUR 709 |
 0,1ML THIN WALL TUBES 8 PER STRIP. WHITE & REAL TIME STRIP CAPS |
|||
| PCR-0108-LP-RT-W | CORNING | 125/pk | EUR 770 |
) Desmin, Clone D33 (Ready-To-Use) |
|||
| A00007-0002 | ScyTek Laboratories | 2 ml | EUR 93 |
Desmin, Clone D33 (Ready-To-Use) |
|||
| A00007-0007 | ScyTek Laboratories | 7 ml | EUR 140 |
Desmin, Clone D33 (Ready-To-Use) |
|||
| A00007-0025 | ScyTek Laboratories | 25 ml | EUR 361 |
) Melanoma; Clone HMB45 (Ready-To-Use) |
|||
| A00019-0002 | ScyTek Laboratories | 2 ml | EUR 183 |
Melanoma; Clone HMB45 (Ready-To-Use) |
|||
| A00019-0007 | ScyTek Laboratories | 7 ml | EUR 258 |
Melanoma; Clone HMB45 (Ready-To-Use) |
|||
| A00019-0025 | ScyTek Laboratories | 25 ml | EUR 781 |
) Neurofilament; Clone 2F11 (Ready-To-Use) |
|||
| A00020-0002 | ScyTek Laboratories | 2 ml | EUR 96 |
Neurofilament; Clone 2F11 (Ready-To-Use) |
|||
| A00020-0007 | ScyTek Laboratories | 7 ml | EUR 144 |
Neurofilament; Clone 2F11 (Ready-To-Use) |
|||
| A00020-0025 | ScyTek Laboratories | 25 ml | EUR 370 |
; Polyclonal (Ready-To-Use)) Lysozyme (Muramidase); Polyclonal (Ready-To-Use) |
|||
| A00033-0002 | ScyTek Laboratories | 2 ml | EUR 79 |
Lysozyme (Muramidase); Polyclonal (Ready-To-Use) |
|||
| A00033-0007 | ScyTek Laboratories | 7 ml | EUR 108 |
Lysozyme (Muramidase); Polyclonal (Ready-To-Use) |
|||
| A00033-0025 | ScyTek Laboratories | 25 ml | EUR 252 |
) S-100; Polyclonal (Ready-To-Use) |
|||
| A00036-0002 | ScyTek Laboratories | 2 ml | EUR 79 |
S-100; Polyclonal (Ready-To-Use) |
|||
| A00036-0007 | ScyTek Laboratories | 7 ml | EUR 108 |
S-100; Polyclonal (Ready-To-Use) |
|||
| A00036-0025 | ScyTek Laboratories | 25 ml | EUR 218 |
) CD74; Clone LN2 (Ready-To-Use) |
|||
| A00048-0002 | ScyTek Laboratories | 2 ml | EUR 84 |
CD74; Clone LN2 (Ready-To-Use) |
|||
| A00048-0007 | ScyTek Laboratories | 7 ml | EUR 116 |
CD74; Clone LN2 (Ready-To-Use) |
|||
| A00048-0025 | ScyTek Laboratories | 25 ml | EUR 245 |
) Thyroglobulin; Clone 2H11 (Ready-To-Use) |
|||
| A00108-0002 | ScyTek Laboratories | 2 ml | EUR 80 |
Thyroglobulin; Clone 2H11 (Ready-To-Use) |
|||
| A00108-0007 | ScyTek Laboratories | 7 ml | EUR 127 |
Thyroglobulin; Clone 2H11 (Ready-To-Use) |
|||
| A00108-0025 | ScyTek Laboratories | 25 ml | EUR 280 |
) CD31; Clone C31.7 (Ready-To-Use) |
|||
| A00110-0002 | ScyTek Laboratories | 2 ml | EUR 104 |
CD31; Clone C31.7 (Ready-To-Use) |
|||
| A00110-0007 | ScyTek Laboratories | 7 ml | EUR 183 |
CD31; Clone C31.7 (Ready-To-Use) |
|||
| A00110-0025 | ScyTek Laboratories | 25 ml | EUR 449 |
; Polyclonal (Ready-To-Use)) p40 (DeltaNp63); Polyclonal (Ready-To-Use) |
|||
| A00112-0002 | ScyTek Laboratories | 2 ml | EUR 116 |
p40 (DeltaNp63); Polyclonal (Ready-To-Use) |
|||
| A00112-0007 | ScyTek Laboratories | 7 ml | EUR 213 |
p40 (DeltaNp63); Polyclonal (Ready-To-Use) |
|||
| A00112-0025 | ScyTek Laboratories | 25 ml | EUR 537 |
) Kappa; Clone L1C1 (Ready-To-Use) |
|||
| A00113-0002 | ScyTek Laboratories | 2 ml | EUR 69 |
Kappa; Clone L1C1 (Ready-To-Use) |
|||
| A00113-0007 | ScyTek Laboratories | 7 ml | EUR 95 |
Kappa; Clone L1C1 (Ready-To-Use) |
|||
| A00113-0025 | ScyTek Laboratories | 25 ml | EUR 188 |
) CD56; Clone 123C3 (Ready-To-Use) |
|||
| A00121-0002 | ScyTek Laboratories | 2 ml | EUR 104 |
CD56; Clone 123C3 (Ready-To-Use) |
|||
| A00121-0007 | ScyTek Laboratories | 7 ml | EUR 183 |
CD56; Clone 123C3 (Ready-To-Use) |
|||
| A00121-0025 | ScyTek Laboratories | 25 ml | EUR 449 |
) CD31; Clone C31.3 (Ready-To-Use) |
|||
| A00126-0002 | ScyTek Laboratories | 2 ml | EUR 82 |
CD31; Clone C31.3 (Ready-To-Use) |
|||
| A00126-0007 | ScyTek Laboratories | 7 ml | EUR 130 |
CD31; Clone C31.3 (Ready-To-Use) |
|||
| A00126-0025 | ScyTek Laboratories | 25 ml | EUR 290 |
) CD45; Clone 2B11 (Ready-To-Use) |
|||
| A00129-0002 | ScyTek Laboratories | 2 ml | EUR 120 |
CD45; Clone 2B11 (Ready-To-Use) |
|||
| A00129-0007 | ScyTek Laboratories | 7 ml | EUR 223 |
CD45; Clone 2B11 (Ready-To-Use) |
|||
| A00129-0025 | ScyTek Laboratories | 25 ml | EUR 572 |
) Tyrosinase; Clone T311 (Ready-To-Use) |
|||
| A00132-0002 | ScyTek Laboratories | 2 ml | EUR 90 |
Tyrosinase; Clone T311 (Ready-To-Use) |
|||
| A00132-0007 | ScyTek Laboratories | 7 ml | EUR 151 |
Tyrosinase; Clone T311 (Ready-To-Use) |
|||
| A00132-0025 | ScyTek Laboratories | 25 ml | EUR 353 |
) CDX2; Clone EP25 (Ready-To-Use) |
|||
| A00147-0002 | ScyTek Laboratories | 2 ml | EUR 149 |
CDX2; Clone EP25 (Ready-To-Use) |
|||
| A00147-0007 | ScyTek Laboratories | 7 ml | EUR 295 |
CDX2; Clone EP25 (Ready-To-Use) |
|||
| A00147-0025 | ScyTek Laboratories | 25 ml | EUR 786 |
) MSH6; Clone EP49 (Ready-To-Use) |
|||
| A00149-0002 | ScyTek Laboratories | 2 ml | EUR 104 |
MSH6; Clone EP49 (Ready-To-Use) |
|||
| A00149-0007 | ScyTek Laboratories | 7 ml | EUR 184 |
MSH6; Clone EP49 (Ready-To-Use) |
|||
| A00149-0025 | ScyTek Laboratories | 25 ml | EUR 453 |
 Ready-To-Use) Peroxide Block (Stable) Ready-To-Use |
|||
| HP1000-10 | Innovex | 10ml | EUR 125 |
Peroxide Block (Stable) Ready-To-Use |
|||
| HP1000-500 | Innovex | 500 ml | EUR 485 |
Peroxide Block (Stable) Ready-To-Use |
|||
| HP1000-60 | Innovex | 60 ml | EUR 241 |
 Ready-to-use Apoptosis Inducer Set |
|||
| K121-5 | Biovision | EUR 392 | |
 Green-DNA Dye, ready to use |
|||
| DT81414 | Bio Basic | 1.5ml, 1.5ml | EUR 128.3 |
|
|||
 Eco-Stain Plus, ready to use |
|||
| DT81418 | Bio Basic | 1ml | EUR 137 |
|
|||
 100-3000bp Marker, Ready-to-use |
|||
| GM347 | Bio Basic | 50loading, 50prep | EUR 90.02 |
|
|||
) Bcl-2; Clone 100/D5 (Ready-To-Use) |
|||
| A00119-0002 | ScyTek Laboratories | 2 ml | EUR 69 |
Bcl-2; Clone 100/D5 (Ready-To-Use) |
|||
| A00119-0007 | ScyTek Laboratories | 7 ml | EUR 95 |
Bcl-2; Clone 100/D5 (Ready-To-Use) |
|||
| A00119-0025 | ScyTek Laboratories | 25 ml | EUR 188 |
Bcl-2; Clone 100/D5 (Ready-To-Use) |
|||
| A00119-0500 | ScyTek Laboratories | 500 ml | EUR 2251 |
 100 bp-10 Kb Wide Range DNA Logical Marker, Ready-to-use |
|||
| M103R-2 | Bio Basic | 5x100loading, 500prep | EUR 363.2 |
|
|||
 0.2ML THIN WALL CLEAR PCR STRIP TUBES AND FLAT STRIP CAPS. 12 TUBES/CAPS PER STRIP |
|||
| PCR-0212-FCP-C | CORNING | 80/pk | EUR 648 |
 SAM Test Strip |
|||
| TS00201s-30 | Arthus | 30 tests | EUR 416 |
 SAH Test Strip |
|||
| TS00301s-30 | Arthus | 30 tests | EUR 504 |
 HCY Test Strip |
|||
| TS00401s-30 | Arthus | 30 tests | EUR 553 |
 Ready-to-Use Tyramide Amplification Buffer, 1X |
|||
| 9-22027 | Biotium |
|
|
 Ready-to-Use 1 KB DNA Ladder |
|||
| 31022 | Biotium | 1kit | EUR 134 |
 Ready-to-Use 100 BP DNA Ladder |
|||
| 31032 | Biotium | 1kit | EUR 134 |
CONCLUSIONS
This report presents the primary two-year knowledge of denosumab remedy in sufferers with Osteogenesis imperfecta sort VI and in Osteogenesis imperfecta on the whole as an efficient and apparently protected remedy possibility.